SUVmax of 2.5 should not be embraced as a magic threshold for separating benign from malignant lesions.
about
The hypermetabolic giant: 18F-FDG avid giant cell tumor identified on PET-CT.18F-FDG PET/CT assessment of histopathologically confirmed mediastinal lymph nodes in non-small cell lung cancer using a penalised likelihood reconstructionNovel penalised likelihood reconstruction of PET in the assessment of histologically verified small pulmonary nodules.Phantom and Clinical Evaluation of the Bayesian Penalized Likelihood Reconstruction Algorithm Q.Clear on an LYSO PET/CT System.Imaging of solitary pulmonary nodule-a clinical reviewThe predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: low-dose fractionated radiotherapy with concurrent chemotherapyAdaptive threshold segmentation of pituitary adenomas from FDG PET images for radiosurgery.Advantages of (18)F FDG-PET/CT over Conventional Staging for Sarcoma Patients.Correction for Partial Volume Effect Is a Must, Not a Luxury, to Fully Exploit the Potential of Quantitative PET Imaging in Clinical Oncology.Molecular response assessed by (68)Ga-DOTANOC and survival after (90)Y microsphere therapy in patients with liver metastases from neuroendocrine tumours.18F-FDG PET-derived parameters as prognostic indices in hepatic malignancies after 90Y radioembolization: is there a role?The kinetics of F-FDG in lung cancer: compartmental models and voxel analysis
P2860
Q34564375-CE8C7262-C739-4263-B1F7-615D419D50ADQ35935680-57E52E59-8FF2-436E-B3B5-981B95189C75Q36001031-223DF2D4-3FA6-4149-97DC-6888E6E4784EQ36023565-49CE0324-DA3E-4EC5-A324-8EFB923B4E94Q37441366-8650608C-83BA-49D4-A814-86921B16589DQ37566016-B3AB924F-EC28-490B-A7E5-0AEC1E2F233BQ41706913-849EBBD4-6962-4A33-9CCA-0FF66B11069EQ47831312-25F5B56C-5AC5-480D-BE49-396DECCA68C2Q48538174-48CA6E4B-6B56-4D1C-8C64-8C28E7A623DCQ51789503-2B9CF14E-8176-488D-B630-175BE323ADA0Q53036718-905EE55D-7181-4619-B419-D4EBBDC61C9FQ58695831-541C2CCE-318E-4032-8421-66AE16D31B57
P2860
SUVmax of 2.5 should not be embraced as a magic threshold for separating benign from malignant lesions.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
SUVmax of 2.5 should not be em ...... benign from malignant lesions.
@en
SUVmax of 2.5 should not be em ...... benign from malignant lesions.
@nl
type
label
SUVmax of 2.5 should not be em ...... benign from malignant lesions.
@en
SUVmax of 2.5 should not be em ...... benign from malignant lesions.
@nl
prefLabel
SUVmax of 2.5 should not be em ...... benign from malignant lesions.
@en
SUVmax of 2.5 should not be em ...... benign from malignant lesions.
@nl
P2093
P2860
P1476
SUVmax of 2.5 should not be em ...... benign from malignant lesions.
@en
P2093
Abass Alavi
Gang Cheng
Marnix G E H Lam
Sandip Basu
Thomas C Kwee
P2860
P2888
P304
P356
10.1007/S00259-013-2484-X
P577
2013-10-01T00:00:00Z